Evidence method
Level · gp.fundamentals.debt_to_revenue
422.97% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BMRN · Jun 30, 2026
BIOMARIN PHARMACEUTICAL INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001048477-26-000016General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.91% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.99% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
19.91% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
180.11% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
79.51% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
11.21% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
20.91% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
7.65% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Period transition
What moved in the state?
- Previous
- 186.67%
- Current
- 422.97%
- Delta
- 236.30%
- Previous
- 2.73%
- Current
- 2.91%
- Delta
- 0.18%
- Previous
- 28.80%
- Current
- 16.99%
- Delta
- -11.81%
- Previous
- 2.83%
- Current
- 19.91%
- Delta
- 17.08%
- Previous
- 166.17%
- Current
- 180.11%
- Delta
- 13.93%
- Previous
- 74.55%
- Current
- 79.51%
- Delta
- 4.96%
- Previous
- 16.92%
- Current
- 11.21%
- Delta
- -5.71%
- Previous
- 23.34%
- Current
- 20.91%
- Delta
- -2.42%
- Previous
- 5.67%
- Current
- 7.65%
- Delta
- 1.98%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Derived From · BMRN Company Quality Vector →Has State · BIOMARIN PHARMACEUTICAL INC →Transitioned To · BMRN Fundamental State →Transitioned To · BMRN BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · BMRN CAPEX_INTENSITY_INCREASED →Transitioned To · BMRN CASH_GENERATION_DECREASED →Transitioned To · BMRN GROWTH_INCREASED →Transitioned To · BMRN INVENTORY_PRESSURE_INCREASED →Transitioned To · BMRN MARGIN_INCREASED →Transitioned To · BMRN PROFITABILITY_DECREASED →Transitioned To · BMRN R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.